Susquehanna Portfolio Strategies
CABA icon

Susquehanna Portfolio Strategies’s Cabaletta Bio CABA Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Buy
383,294
+365,699
+2,078% +$1.2M 0.02% 534
2026
Q1 		$47.3K Buy
+17,595
New +$48.9K ﹤0.01% 952
2025
Q4 		– Sell
-33,937
Closed -$79.4K – 1016
2025
Q3 		$79.4K Buy
+33,937
New +$58.2K ﹤0.01% 1013

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Susquehanna Portfolio Strategies's CABA Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its Cabaletta Bio (CABA) stake by 2,078% in Q2 2026, buying an estimated $1.2M and bringing the position to 383,294 shares worth $1.19M. The position accounts for 0.02% of the portfolio, ranked #534.

Susquehanna Portfolio Strategies first reported a position in CABA in Q3 2025 and has held it in 3 quarters since. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Susquehanna Portfolio Strategies held 383,294 shares of Cabaletta Bio worth $1.19M as of Q2 2026.
  • Susquehanna Portfolio Strategies bought 365,699 Cabaletta Bio shares in Q2 2026, an estimated $1.2M.
  • Cabaletta Bio made up 0.02% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #534 holding.
  • Susquehanna Portfolio Strategies first reported a position in Cabaletta Bio in Q3 2025 and has held it in 3 quarters since.
  • 139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.